NEW YORK, March 24, 2016 -- The Securities Arbitration Law Firm of Klayman & Toskes, P.A. (“K&T”), www.nasd-law.com, announces an investigation into Financial Industry Regulatory Authority (FINRA) sales practice violations by Cetera Advisors related to solicited investments in non-traded Real Estate Investment Trusts (“REITs”) and Business Development Companies (“BDCs”). According to K&T, the scope of the investigation includes whether Cetera Advisors made suitable recommendations related to non-traded REITs and BDCs; whether adequate disclosure was made of the fees, costs and risks of non-traded REITs and BDCs and whether the high commissions paid to Cetera Advisors resulted in conflicts of interest.
Effective April 11, 2016, new regulations related to valuation disclosure requirements, FINRA Notice to Members 15-02, instruct brokerage firms to be more transparent through greater disclosure concerning non-traded REITs and BDCs on account statements. Securities attorney Steven D. Toskes, Esq. comments on the new regulatory notice, ”Investors will now receive more accurate disclosure for non-traded REITs and BDCs, including valuations of deductions for syndication costs, as high as 10%, and any changes in the value of underlying assets.” Mr. Toskes explains, “Our investigation is to determine whether financial advisors failed to adequately disclose the risks related to liquidity and effects of syndication costs on the valuation of non-trade REITs and BDCs.”
Our investigation of Cetera Advisors includes sales practices violations related to investments in non-traded REITs and BDCs include, but not limited, to the following:
America Realty Capital Properties (Vereit);
Cole Capital REITs;
CNL Corporate Capital Trust;
Franklin Square Energy and Power Fund;
Griffin Capital;
Northstar Real Estate Income; and
Sierra Income Corporation.
FINRA sales practice rules related to potential violations may include misrepresentations and omissions of material facts, conflicts of interest, unsuitable investment advice, securities concentration, or failure to supervise its financial advisors. Our investigation relates to Cetera Advisors solicited investments in non-traded REITs and BDCs for customer accounts.
About Klayman & Toskes, P.A.
K&T is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation, on behalf of retail and institutional investors such as non-profit organizations, public and multi-employer pension funds in large and complex securities matters. K&T has office locations in California, Florida, New York and Puerto Rico. If you wish to discuss this announcement or have knowledge of Cetera Advisors’ sales practices related to non-traded REITs and BDCs can contact us, or call Steven D. Toskes, Esq. at 888-997-9956.
Contact: Klayman & Toskes, PA Steven D. Toskes, Esq. 888-997-9956 [email protected] www.nasd-law.com


Bain Capital Moves to Acquire Majority Stake in Echo Marketing
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 



